Ziel
Hantaviruses are health threatening infectious agents causing hemorrhagic fevers with renal syndrome in humans. In Europe, the hantaviruses Pamela and Do Brava have been identified as the main pathogens. There is an urgent need for a development of a bivalent vaccine protecting occupational risk groups and inhabitants of hyper endemic regions against infections by these two viruses.
Wissenschaftliches Gebiet
Programm/Programme
Aufforderung zur Vorschlagseinreichung
Data not availableFinanzierungsplan
CSC - Cost-sharing contractsKoordinator
10117 Berlin
Deutschland